Alpha 2.0
Login Register
» Authors » L Hegedus

L Hegedus

Explore the profile of L Hegedus including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 243
Citations 2174
Followers 0
Related Specialties
Endocrinology
General Medicine
Allergy & Immunology
Top 10 Co-Authors
J M Hansen
S Karstrup
B Nygaard
U Feldt-Rasmussen
F N Bennedbaek
T H Brix
M Hoier-Madsen
H Perrild
S J Bonnema
H H Holm
Published In
Ugeskr Laeger
Clin Endocrinol (Oxf)
J Clin Endocrinol Metab
J Endocrinol Invest
Thyroid
Affiliations
Soon will be listed here.
Recent Articles
1.
Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration
Galofre J, Diez J, Attanasio R, Nagy E, Negro R, Papini E, et al.
J Endocrinol Invest . 2024 Jun; 48(1):201-212. PMID: 38878126
Purpose: The use of thyroid hormones (TH) to treat obesity is unsupported by evidence as reflected in international guidelines. We explored views about this practice, and associations with respondent characteristics...
2.
Do bone turnover markers reflect changes in bone microarchitecture during treatment of patients with thyroid dysfunction?
Vinther C, Poulsen L, Nicolaisen P, Obling M, Brix T, Hermann A, et al.
J Endocrinol Invest . 2022 Sep; 46(2):345-358. PMID: 36064878
Purpose: This study aimed to compare changes in the bone turnover markers (BTMs)-C-terminal telopeptide of type I collagen (CTX-I) and procollagen I N-terminal peptide (PINP)-with changes in the bone microarchitecture,...
3.
[Features of the use of synthetic analogues of thyroid hormones: а 2020 THESIS* questionnaire survey of members of the Belarusian Public Medical Association of Endocrinology and Metabolism]
Shepelkevich A, Dydyshka Y, Yurenya E, Lobashova V, Attanasio R, Hegedus L, et al.
Probl Endokrinol (Mosk) . 2022 Mar; 68(1):18-26. PMID: 35262294
Background: The standard treatment for hypothyroidism is levothyroxine (LT4), which in the Republic of Belarus is available in tablet form whereas liothyronine (LT3) is not registered, but patients can purchase...
4.
Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: A Thesis* Questionnaire Survey of Romanian Physicians *Thesis: Treatment of Hypothyroidism in Europe by Specialists: an International Survey
Niculescu D, Attanasio R, Hegedus L, Nagy E, Negro R, Papini E, et al.
Acta Endocrinol (Buchar) . 2021 Jun; 16(4):462-469. PMID: 34084238
Objective: Romania has no national guidelines for hypothyroidism treatment, nor are there any recommendations from national societies to adhere to international guidelines. Our aim was to identify the attitudes of...
5.
Use of thyroid hormones in hypothyroid and euthyroid patients: A 2020 THESIS questionnaire survey of members of the Danish Endocrine Society
Riis K, Frolich J, Hegedus L, Negro R, Attanasio R, Nagy E, et al.
J Endocrinol Invest . 2021 Mar; 44(11):2435-2444. PMID: 33774809
Purpose: The standard treatment of hypothyroidism is levothyroxine (LT4), which is available as tablets or soft-gel capsules in Denmark. This study aimed to investigate Danish endocrinologists' use of thyroid hormones...
6.
Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment
Zarkovic M, Wiersinga W, Perros P, Bartalena L, Donati S, Okosieme O, et al.
J Endocrinol Invest . 2020 Jun; 44(2):371-378. PMID: 32524368
Purpose: Whereas antithyroid drugs (ATD) are the preferred treatment modality for Graves' hyperthyroidism (GH), there is still controversy about the optimal regimen for delivering ATD. To evaluate whether 'Block and...
7.
Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study
Perros P, Zarkovic M, Panagiotou G, Azzolini C, Ayvaz G, Baldeschi L, et al.
J Endocrinol Invest . 2020 Jun; 43(12):1717-1722. PMID: 32474767
Purpose: Patients with Graves' orbitopathy can present with asymmetric disease. The aim of this study was to identify clinical characteristics that distinguish asymmetric from unilateral and symmetric Graves' orbitopathy. Methods:...
8.
THE ROMANIAN VERSION OF THE THYROID-RELATED PATIENT-REPORTED OUTCOMES THYPRO AND THYPRO-39. TRANSLATION AND ASSESSMENT OF RELIABILITY AND CROSS-CULTURAL VALIDITY
Zahan A, Watt T, Pascanu I, Rasmussen A, Hegedus L, Bonnema S, et al.
Acta Endocrinol (Buchar) . 2019 Jun; 14(2):192-200. PMID: 31149257
Background: ThyPRO is a recently developed thyroid-specific quality of life (QoL) questionnaire applicable to patients with benign thyroid disorders(BTD). The aim of the present study was to translate ThyPRO and...
9.
Hyperthyroid patients without Graves' orbitopathy are not at increased risk of developing glaucoma: a nationwide Danish register-based case-control study
Brandt F, Thvilum M, Hegedus L, Brix T
Endocrine . 2017 Dec; 59(1):137-142. PMID: 29198022
Purpose: Graves' disease (GD) and toxic nodular goiter (TNG) are associated with various comorbidities. However, it is unclarified whether TNG and GD without orbitopathy are associated with glaucoma. Methods: This...
10.
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement
Perros P, Hegedus L, Bartalena L, Marcocci C, Kahaly G, Baldeschi L, et al.
Orphanet J Rare Dis . 2017 Apr; 12(1):72. PMID: 28427469
Background: Graves' orbitopathy (GO) is an autoimmune condition, which is associated with poor clinical outcomes including impaired quality of life and socio-economic status. Current evidence suggests that the incidence of...